Labshake search
Citations for R&D Systems :
401 - 450 of 3153 citations for 1 Benzyl 3 Tert Butyldimethylsilyl Oxy Methyl Piperidin 4 One since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2024Quote: ... and 21 ng/mL BMP-4 (R&D Systems, 5020-BP) for 3 days.
-
bioRxiv - Cell Biology 2021Quote: ... Spain) and supplemented with each one of the following combinations of growth factors: (i) 100 ng/ml Act A (R&D Systems, UK), (ii ...
-
bioRxiv - Immunology 2022Quote: ... Detection of bound sIL7R was carried out by one-hour incubation at room temperature with biotinylated goat anti-human IL7R polyclonal antibody (R&D Systems, # BAF306), followed by 30-minute incubation at room temperature with streptavidin-horseradish peroxidase (Millipore Sigma ...
-
bioRxiv - Neuroscience 2022Quote: YKL-40 concentrations in the CSF were quantitated in one round of analyses with one batch of reagents according to the manufacturer’s instructions using a commercially ELISA kit (R&D Systems, Minneapolis, MN) according to instructions from the manufacturer instructions ...
-
bioRxiv - Cell Biology 2022Quote: ... primary BMSCs were plated in 6-well dishes until 80% confluent and serum starved (0.5% FBS) for 72 hours prior to treatment with one or a combination of CXCL12 (200 ng/ml, R&D Systems, 460-SD) and Wnt3a (100 ng/ml ...
-
bioRxiv - Cell Biology 2022Quote: ... primary BMSCs isolated from C57BL/6 mice were plated in 6-well dishes until 80% confluent and serum starved (0.5% FBS) for 48 hours prior to treatment with one or a combination of CXCL12 (200 ng/ml, R&D Systems, 460-SD), Wnt3a (100 ng/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... cocultures were treated with 3 μg/ml IL1α-neutralizing antibody (#MAB4001, R&D Systems) or isotype control antibody (#400902 ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
bioRxiv - Neuroscience 2021Quote: VEGF165b (3 – 30 ng; 5 µl; cat. #3045-VE-025, R&D System, USA), PlGF-2 (3 – 30 ng ...
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Microbiology 2023Quote: Calu-3 cells were treated with exogenous β-IFN (R&D Systems, Minneapolis MN), baricitinib (Selleck Chemicals ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/ml IL-3 and 80 ng/ml M-CSF (R&D Systems). On day 13 ...
-
bioRxiv - Neuroscience 2021Quote: 10 ng/mL BMP-4 (R&D Systems cat. no. 314-BP)
-
bioRxiv - Immunology 2020Quote: ... and IL-4 (R&D Systems cat. 404-ML, 10 ng/ml) in RPMI 1640 medium (Gibco cat ...
-
bioRxiv - Immunology 2020Quote: ... 25ng/ml IL-4 (404-ML-025, R&D Systems, Minneapolis MN) and 25ng/ml IL-21(210-21 ...
-
bioRxiv - Biochemistry 2021Quote: Four 4× stock solutions were prepared containing (i) Ube1 (R&D Systems) + UbcH5c/UBE2D3 (R&D Systems ...
-
bioRxiv - Immunology 2020Quote: ... and IL-4 (R&D Systems cat. 204-IL, 35 ng/ml) in RPMI 1640 medium supplemented with 10% FBS and 2-Mercaptoethanol ...
-
bioRxiv - Cancer Biology 2023Quote: ... Th2 condition: Recombinant human IL-4 (10 ng/ml, R&D Systems), IL-5 (10 ng/ml ...
-
bioRxiv - Neuroscience 2023Quote: ... and stage-specific embryonic antigen-4 (SSEA4, R&D Systems, Minneapolis, USA) using immunocytochemistry (ICC) ...
-
bioRxiv - Immunology 2023Quote: ... Concentration of sCTLA-4 was estimated by ELISA (R&D Systems, DY476) or SDS-PAGE/CBB staining with bovine serum albumin (BSA ...
-
CRISPR-Cas9 Engineered Extracellular Vesicles for the Treatment of Dominant Progressive Hearing LossbioRxiv - Bioengineering 2023Quote: ... specimens were stained with anti-4 hydroxynonenal (R&D Systems MSB 3249) or anti 3-nitrotyrosine ...
-
bioRxiv - Neuroscience 2023Quote: ... or anti-toll-like receptor 4 (TLR4; clone #610029, R&D Systems). All antibodies were titrated using negative control cells that don’t or poorly express the target protein ...
-
bioRxiv - Cell Biology 2022Quote: ... and Laminin (R&D Systems #3446-005-01, 4-8 µg/cm2) coated glass-bottom Petri dishes (Greiner Bio-One #627975 ...
-
bioRxiv - Genomics 2023Quote: ... followed by recombinant human BMP-4 (5 ng/mL; R&D Systems) and CHIR 99021 (1 nM ...
-
bioRxiv - Immunology 2024Quote: ... 4) IL1B/IL1F2 DuoSet ELISA kits (R&D Systems, Minneapolis, MN, USA), following manufacturer’s protocols ...
-
bioRxiv - Immunology 2024Quote: ... anti- IL-4 and 2 ng/ml rhTGF-β1 (R&D Systems).
-
bioRxiv - Cancer Biology 2024Quote: ... The ligands used were His-Tagged human Nectin-4 (R&D systems, catalog # 2659-N4-050 ...
-
bioRxiv - Systems Biology 2021Quote: ... we added one or combinations of the following recombinant proteins to the medium: 200 ng/mL of recombinant mouse FGF4 (R&D Systems, #7486-F4), 200 ng/mL of recombinant human FGF5 (R&D Systems ...
-
bioRxiv - Microbiology 2020Quote: ... phosphorylated CREB (pCREB) and cleaved caspase-3 were measured using ELISA kits (R&D Systems) according to the manufacturer’s instructions.
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Microbiology 2023Quote: ... and recombinant mouse IL-3 (10 ng/mL; R&D Systems, Cat. No. 403-ML). Cells were plated at a density of 1 × 106 cells/mL in a T-75 cm2 flask ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 20 ng/mL IL-3 and 20 ng/mL SCF (R&D Systems), 2% FBS ...
-
bioRxiv - Cell Biology 2023Quote: Primary antibodies used for immunofluorescent staining were: active caspase-3 (Rabbit, R&D Systems, AF835); laminin alpha3 chain (Mouse ...
-
bioRxiv - Cell Biology 2022Quote: ... then plated into T175 flasks with Interleukin-3 (IL3, R&D Systems, 203-IL-050) and macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... were performed followed by one round of in solution selection with 50 nM in-house biotinylated human MOG (hMOG) (R&D Systems, Minneapolis, MN, USA). Thereafter ...
-
bioRxiv - Cell Biology 2020Quote: ... and BMP4-Lif (10 ng/mL of mouse BMP-4 R&D Systems,Inc. ...
-
bioRxiv - Genomics 2020Quote: ... 4 μg normal rabbit IgG (R&D Systems, AB-105-C, lot: ER1212071) and ChIP-grade protein G magnetic beads (Cell Signalling 9006S ...
-
bioRxiv - Immunology 2022Quote: ... 30 μg/mL LPS plus 25 ng/mL IL-4 (R&D Systems); or 5 μg/mL LPS ...
-
bioRxiv - Cell Biology 2022Quote: ... and human bone morphogenetic protein 4 (hBMP4, 1.5 ng/ml; R&D Systems) together with human vascular endothelial growth factor (hVEGF ...
-
bioRxiv - Neuroscience 2022Quote: ... 25 µg/ml human recombinant Bone Morphogenetic Protein 4 (BMP4, R&D Systems) and 55 µM β-mercaptoethanol (Life technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Neuroscience 2020Quote: ... Antibodies used to assess pluripotency were anti-OCT3/4 (R&D Systems AF1759), anti-SOX2 (BD 245619) ...
-
bioRxiv - Immunology 2022Quote: ... or 4 μg/mL of anti-CCL1 Ab (clone 148113; R&D Systems), was added to the cultures.
-
bioRxiv - Immunology 2022Quote: ... 4 μg/mL of anti-CCL5 Ab (polyclonal goat IgG; R&D Systems), or 4 μg/mL of anti-CCL1 Ab (clone 148113 ...
-
bioRxiv - Cell Biology 2024Quote: ... 15 ng/mL BMP-4 (314-BP-050/CF; R&D Systems Inc) and 125 ng/mL Fibroblast growth factor (FGF ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Bioengineering 2023Quote: ... at 4°C for 16 h and measured via ELISA (R&D Systems). The distribution of TGF-β in Ø2×2 mm and Ø5×2 mm constructs was predicted via FE model (FEBio ...